| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| ADH1C |
P00326
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
Enzyme
|
|
0.547 |
0.731 |
| AMD1P2 |
|
adenosylmethionine decarboxylase 1 pseudogene 2
|
|
|
0.608 |
0.538 |
| ANCR |
|
Angelman syndrome chromosome region
|
|
|
0.751 |
0.154 |
| APOC1P1 |
|
apolipoprotein C1 pseudogene 1
|
|
|
0.890 |
0.154 |
| ATHS |
|
atherosclerosis susceptibility (lipoprotein associated)
|
|
|
0.551 |
0.769 |
| BAGE |
Q13072
|
B melanoma antigen
|
|
|
0.711 |
0.346 |
| BCYRN1 |
|
brain cytoplasmic RNA 1
|
|
|
0.666 |
0.423 |
| BTF3P11 |
|
basic transcription factor 3 pseudogene 11
|
|
|
0.519 |
0.731 |
| GAS8-AS1 |
O95177
|
GAS8 antisense RNA 1
|
|
|
0.751 |
0.192 |
| CCT |
|
cataract, congenital, total
|
|
|
0.588 |
0.769 |
| CDR1 |
P51861
|
cerebellar degeneration related protein 1
|
|
|
0.576 |
0.808 |
| CTAA1 |
|
cataract, anterior polar 1
|
|
|
0.568 |
0.731 |
| CTAG1B |
P78358
|
cancer/testis antigen 1B
|
|
|
0.507 |
0.731 |
| CYP2D7 |
A0A087X1C5
|
cytochrome P450 family 2 subfamily D member 7 (gene/pseudogene)
|
|
|
0.659 |
0.577 |
| DEFA1 |
P59665
|
defensin alpha 1
|
|
|
0.636 |
0.731 |
| EEF1B2P2 |
|
eukaryotic translation elongation factor 1 beta 2 pseudogene 2
|
|
|
0.612 |
0.577 |
| ERV3-1 |
Q14264
|
endogenous retrovirus group 3 member 1, envelope
|
|
|
0.700 |
0.423 |
| FKBP1AP1 |
|
FKBP prolyl isomerase 1A pseudogene 1
|
|
|
0.700 |
0.538 |
| FKBP1AP2 |
|
FKBP prolyl isomerase 1A pseudogene 2
|
|
|
0.700 |
0.538 |
| FKBP1AP3 |
|
FKBP prolyl isomerase 1A pseudogene 3
|
|
|
0.700 |
0.538 |
| FKBP1AP4 |
|
FKBP prolyl isomerase 1A pseudogene 4
|
|
|
0.700 |
0.538 |
| FPR1 |
P21462
|
formyl peptide receptor 1
|
G-protein coupled receptor
|
|
0.576 |
0.769 |
| FRA6E |
|
fragile site, aphidicolin type, common, fra(6)(q26)
|
|
|
0.792 |
0.231 |
| FRA7G |
|
fragile site, aphidicolin type, common, fra(7)(q31.2)
|
|
|
0.695 |
0.462 |